USPTO serial 79066787
Serial No. 79066787
Reviewed by CopyMark Law Group
Reg. 3763394Status 404
- Filing date
- Status date
- Registration date
- Mar 23, 2010
- Examiner
- STEIN, JAMES W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79066787?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JOHN P. MURTAUGH
JOHN P. MURTAUGH PEARNE & GORDON LLP1801 EAST 9TH STREET, SUITE 1200CLEVELAND, OH 44114-3108UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and cultures of micro-organisms, in particular bacteria, bifid bacteria, yeast and fermented milk products, fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings and reared animal species, not for medical or veterinary use, fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried and freeze-dried form | SECTION 71 - CANCELLED | — |
| 005 | Bacterial and bacteriological preparations for medical or veterinary purposes, namely, micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings and reared animal species, for medical or veterinary purposes; bacterial and bacteriological preparations for medical or veterinary purposes, namely, proprietary medicine for treating or eliminating bacteria, fungi and viruses present in tissue, skin and mucous membranes, containing micro-organisms or cultures of micro-organisms; bacterial and bacteriological preparations for medical or veterinary purposes, namely, proprietary medicine containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria for treating the intestinal bacterial flora, for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy, for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora, for treating intestinal dismicrobic syndromes, in particular in diseases linked to changes in the bacterial flora, namely, diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, for producing vitamins, for stimulating the intestinal bacterial flora to produce vitamins; bacterial and bacteriological preparations for medical or veterinary purposes, namely, proprietary medicine to treat diseases of the urinary tract for internal and external use containing micro-organisms or cultures of micro-organisms; bacterial and bacteriological preparations for medical or veterinary purposes, namely, micro-organisms or cultures of micro-organisms, fermented milk products or live fermented milk products in dried or freeze-dried form; bacterial and bacteriological preparations for medical or veterinary purposes, namely, proprietary medicine for treating inflammatory conditions of the prostate gland, in particular prostatitis and prostatic hypertrophy, in pharmaceutical forms for internal and external use containing fermented milk products, live fermented milk products in dried or freeze-dried form, cultures of micro-organisms, cultures of live micro-organisms in dried or freeze-dried form | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| May 17, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 4, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 6, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 6, 2017 | INPC | INVALIDATION PROCESSED | — |
| Jun 28, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 17, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 28, 2016 | C71T | CANCELLED SECTION 71 | — |
| Feb 26, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 27, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 7, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 25, 2011 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 12, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 12, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 23, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 23, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 5, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 5, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 2, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 10, 2009 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 10, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 10, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 2009 | ALIE | ASSIGNED TO LIE | — |
| Oct 28, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 28, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 28, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 29, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 29, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 28, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 27, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 17, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 17, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |